news 2020

« BACK

Pharmacology



Results 61 - 80 of 476.


Health - Pharmacology - 26.10.2020
’Preventive malaria treatment improves children’s performance at school’
UAntwerp involved in large-scale international research to be published in The Lancet. School-aged children who are given anti-malaria drugs preventively are only half as likely to catch the disease. And that's not all: their risk of anaemia decreases by 15%, and their school performance improves. All this has been demonstrated by international research in which the University of Antwerp was also involved.

Pharmacology - Health - 23.10.2020
Is Antimicrobial Resistance Evolution Accelerating?
A team of researchers from Freie Universität Berlin and ETH Zurich studied if antifungal and antibiotic resistance emerge faster than in the past No 199/2020 from Oct 23, 2020 Scientists from Freie Universität Berlin and Eidgenössische Technische Hochschule Zürich (ETH Zurich) investigated how long it takes for resistance to emerge after the introduction of a new antifungal or antibiotic.

Pharmacology - Health - 23.10.2020
Cardiff University-led study into antibiotic use wins research paper of the year
A study into antibiotic use led by Cardiff University and in collaboration with the University of Oxford and King's College London has won research paper of the year. The study, by researchers from Cardiff University's School of Medicine and Centre for Trials Research, found a simple finger-prick blood test could help to prevent unnecessary prescription of antibiotics in patients with chronic obstructive pulmonary disease (COPD).

Health - Pharmacology - 23.10.2020
School children benefit from preventive malaria treatment
A large study shows that preventive treatment of children with antimalarial drugs reduces clinical malaria and anaemia in sub-Saharan Africa. In several regions affected by the tropical disease malaria there are programmes in schools to preventively treat children with antimalarial drugs. An international consortium of researchers, including Michael Zimmermann, Professor of Human Nutrition at ETH Zurich, has now for the first time analysed the effectiveness of such programmes in a meta-analysis using individual data.

Pharmacology - Life Sciences - 22.10.2020
Oxford COVID-19 vaccine follows its programmed genetic instructions, independent analysis finds
The AstraZeneca Oxford COVID-19 vaccine (ChAdOx1 nCoV-19 and also known as AZD1222) now undergoing Phase III clinical trials, has already undergone rigorous testing to ensure the highest standards of quality and safety. Now a team at Bristol University has used recently developed techniques to further validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford team.

Health - Pharmacology - 22.10.2020
Cutting-edge tech propels cardiac surgery forward
Cutting-edge tech propels cardiac surgery forward
In a world-first preclinical study, Australian researchers have shown it could be possible to implant a potentially life-saving pump into the heart of those with heart failure, without leaving the ICU or breaking isolation restrictions for the sickest COVID-19 patients. With up to 40 percent of COVID-19 deaths attributed to heart failure, the work shows immense promise and the researchers are eager to see it progress to human studies.

Health - Pharmacology - 21.10.2020
Palliative care needed across China for everyone who needs it - study
Palliative care should extend across China and pay more attention to managing non-malignant disease - integrated within the country's healthcare system and available to everyone who needs it, according to a new study. Researchers have found that, with rapidly aging populations, there is an increasing need for palliative care across Greater China - Hong Kong, Macao, mainland China and Taiwan - to help improve quality of life, as well as reducing pain, anxiety and depression.

Health - Pharmacology - 21.10.2020
Key research role in COVID-19 Human Challenge Study
Scientists across UCL will play a key role in the world's first human challenge study of the SARS-CoV-2 virus, providing new insight into the body's immune response and finding out which vaccines are likely to work. The COVID-19 Human Challenge Programme, funded through the UK Government's Vaccines Taskforce, is being run in partnership with Imperial College London, the Department for Business, Energy & Industrial Strategy (BEIS), hVIVO, a leading clinical company with expertise in viral human challenge models, and the Royal Free London NHS Foundation Trust.

Pharmacology - Health - 20.10.2020
From pills to powder: 1 in 3 high school seniors who misused prescription opioids later used heroin
Nearly one-third of students who reported misusing prescription opioids as high school seniors between 1997 and 2000, but did not have a history of medical use, later used heroin by age 35, according to a University of Michigan study. The research also found that 21% of seniors in the same period, who misused prescription opioids and later received an opioid prescription, went on to use heroin by age 35, said lead researcher Sean Esteban McCabe, professor and director of the Center for the Study of Drugs, Alcohol, Smoking and Health at the U-M School of Nursing.

Health - Pharmacology - 20.10.2020
Polycystic ovary syndrome treatment may hinge on diet
Sydney researchers have found diet could be a potential intervention for polycystic ovary syndrome after a mouse study showed promising results. The Mediterranean diet may be investigated as a potential treatment for polycystic ovary syndrome after mice with PCOS-like features of the condition were found to benefit from a similar diet.

Health - Pharmacology - 19.10.2020
Medium-term impact of COVID-19 revealed in new study
Initial findings from a study looking at the longer-term impact of COVID-19 has found that a large proportion COVID-19 patients discharged from hospital were still experiencing symptoms of breathlessness, fatigue, anxiety and depression two to three months after contracting the virus. The University of Oxford scientists carrying out the C-MORE study have also detected abnormalities on MRI in multiple organs and believe that persistent or chronic inflammation may be an underlying factor for these changes among COVID-19 survivors.

Health - Pharmacology - 19.10.2020
Online tool could help eliminate TB in countries with low transmission
A new online tool which could help eliminate tuberculosis in countries with low transmission rates such as the UK, by identifying who is at highest risk of developing TB, has been developed by UCL researchers. The research, published today , is the largest study of its kind and pooled data from 18 previous studies and 20 countries including the UK and from across Western Europe, North America and Australia.

Health - Pharmacology - 19.10.2020
Risk predictor could eliminate TB in countries with low transmission
A new online tool which could help eliminate tuberculosis in countries with low transmission rates such as the UK, by identifying who is at highest risk of developing TB, has been developed by UCL researchers. The research, published today , is the largest study of its kind and pooled data from 18 previous studies and 20 countries including the UK and from across Western Europe, North America and Australia.

Health - Pharmacology - 15.10.2020
Non-routine testing of patients with suspected Covid-19 ’of little benefit’ to assess risk
Non-routine testing of patients with suspected Covid-19 to help predict their prognosis on admission to emergency departments offers limited benefit and could have significant cost implications, according to a collaborative evaluation by Cardiff University and the University Hospital of Wales. Researchers drew together laboratory and clinical findings at Wales's largest hospital from the first wave of the pandemic using a newly created electronic healthcare resource, aimed at learning from routine care in the NHS.

Health - Pharmacology - 14.10.2020
Virus-mimicking drug helps immune system target cunning cancer cells
Researchers at the UCLA Jonsson Comprehensive Cancer Center have found that a drug that activates the body's natural defenses by behaving like a virus may also make certain stealthy melanoma tumors visible to the immune system, allowing them to be better targeted by immunotherapy. The findings, published today Translational Medicine, open up the possibility of using drugs that mimic viruses to overcome immunotherapy resistance in tumors with defective interferon signaling and help create more personalized therapies for people with hard-to-treat cancers.

Health - Pharmacology - 13.10.2020
Safely on the way to effective tumour cell killing
Safely on the way to effective tumour cell killing
Scientists at the University of Göttingen develop drug for antibody tumour therapy Chemists at the University of Göttingen have developed new cytotoxic drugs which could revolutionise antibody-based tumour therapy approaches. The research team succeeded in modifying the natural product Duocarmycin into -prodrug- formats - which means that it only develops its effect once inside the tumour cell, thus reducing the likelihood of potential side effects on passage through the body.

Pharmacology - Life Sciences - 12.10.2020
New Device for Detecting Traumatic Brain Injury ’On the Spot’
A method for detecting traumatic brain injury at the point of care has been developed by scientists at the University of Birmingham. Using chemical biomarkers released by the brain immediately after a head injury occurs, researchers are able to pinpoint when patients need urgent medical attention. This saves time in delivering vital treatment and avoids patients undergoing unnecessary tests where no injury has occurred.

Health - Pharmacology - 12.10.2020
Scientists develop new ’Precision Medicine’ approach to treating damaged DNA in Pancreatic Cancer
Scientists have developed a new 'Precision Medicine' approach to treating the damaged DNA in the cancer cells of Pancreatic Cancer patients. The findings mark an important step forward for potential treatment options for pancreatic cancer, improving the options and outcomes for a disease where survival rates have remained stubbornly low.

Health - Pharmacology - 09.10.2020
Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, but a high dose of favipiravir does
Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, but a high dose of favipiravir does
Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose of the anti-flu drug favipiravir, by contrast, has an antiviral effect in the hamsters.

Health - Pharmacology - 06.10.2020
Research suggests significantly less risk of COVID-19 transmission from anaesthesia procedures
Since the outset of the COVID-19 pandemic, there has been much debate about the danger to hospital staff from anaesthetic procedures. Concerns include that placing a tube in the patient's airway (intubation) before surgery or removing it at the end (extubation) may produce a fine mist of small particles (called aerosols) and spread the COVID-19 virus to nearby staff.

This site uses cookies and analysis tools to improve the usability of the site. More information. |